Intensive ldl-c reduction
Intensive ldl-c reduction has been studied in 2 papers since 2026: none in people yet, 2 reviews; 2 in the past year. No study of it in people or animals has been published yet. The newest paper, Nov 6, 2026: “Neurorehabilitation as an Opportunity for Structured Post-Stroke Lipid Management: A Narrative Review”.
2 papers study it2 findingsUpdated
1 new paper in 30 daysSee all 2 papers on intensive ldl-c reduction
What is intensive ldl-c reduction linked with?
1Studies link intensive ldl-c reduction with recurrent ischemic stroke.
Recurrent ischemic stroke
downin humans1downin reviews1
2 studies
Recurrent ischemic stroke
downin humans1downin reviews1
Intensive ldl-c reduction lowers the risk of recurrent ischemic stroke in humans (secondary prevention after ischemic stroke).
“Evidence from SPARCL, Treat Stroke to Target, FOURIER, and Ez PAVE shows that intensive LDL-C reduction improves secondary stroke prevention.”
Reviewsecondary prevention after ischemic stroke
NeuroRehabilitation
Intensive ldl-c reduction lowers the risk of recurrent ischemic stroke.
“Intensive LDL-C reduction significantly lowers recurrent IS risk”
Review
Dyslipidemia management in stroke prevention: An individualized approach
International journal of stroke : official journal of the International Stroke Society